ITEM 8.01 OTHER EVENTS.

On January 5, 2021, Pulse Biosciences, Inc. (the "Company") issued a press release announcing that on December 31, 2020, it delivered a notice of redemption to redeem all of the outstanding warrants (the "Warrants") to purchase shares of the Company's common stock, $0.001 par value per share (the "Common Stock"), issued on June 16, 2020 in connection with the Company's rights offering pursuant to its Registration Statement on Form S-3, as amended (File No. 333-237577). The warrants may be exercised for cash in accordance with the terms therein at any time prior to February 5, 2021, the redemption date for the warrants.

A copy of the press release related to the matters set forth herein is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS



     (d)         Exhibits.

 Exhibit No.     Description
    99.1         Press Release of Pulse Biosciences, Inc. dated January 5, 2021.




?

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses